Drugs that contain Glycopyrronium Tosylate
1. Drug name - QBREXZA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US10548875 | JOURNEY | Glycopyrrolate salts |
Feb, 2033
(10 years from now) | |
| CN105026369A | JOURNEY | Glycopyrronium Salt |
Sep, 2018
(4 years ago) | |
| EP2961734A1 | JOURNEY | Glycopyrrolate Salts |
Feb, 2034
(11 years from now) | |
| EP3473615B1 | JOURNEY | Glycopyrrolate Salts |
Feb, 2034
(11 years from now) | |
| EP2961734B1 | JOURNEY | Glycopyrrolate Salts |
Feb, 2034
(11 years from now) | |
| EP3473615A1 | JOURNEY | Glycopyrrolate Salts |
Feb, 2034
(11 years from now) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US10052267 | JOURNEY | Topical glycopyrrolate formulations |
Oct, 2028
(6 years from now) | |
| US8618160 | JOURNEY | Topical glycopyrrolate formulations |
Dec, 2029
(7 years from now) | |
| US9744105 | JOURNEY | Topical glycopyrrolate formulations |
Jul, 2030
(7 years from now) | |
| US10004717 | JOURNEY | Glycopyrrolate salts |
Feb, 2033
(10 years from now) | |
| US10543192 | JOURNEY | Glycopyrrolate salts |
Feb, 2033
(10 years from now) | |
| US8859610 | JOURNEY | Crystalline glycopyrrolate tosylate |
Feb, 2033
(10 years from now) | |
| US9259414 | JOURNEY | Glycopyrrolate salts |
Feb, 2033
(10 years from now) | |
Treatment: Topical treatment of primary axillary hyperhidrosis in adults and pediatric patients 9 years of age and older
Dosage: CLOTH;TOPICAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 2.4% BASE | CLOTH;TOPICAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.